Abstract
11 Vedolizumab induction therapy for patients with Crohn's disease and prior anti-tumour necrosis factor antagonist failure: a randomised, placebo-controlled, double-blind, multicentre trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have